LTB4R
MOLECULAR TARGETleukotriene B4 receptor
LTB4R (leukotriene B4 receptor) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting LTB4R
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | zileuton | 5.04 | 154 |
| 2 | Leukotriene B4 | 2.71 | 14 |
| 3 | ly 255283 | 2.30 | 9 |
| 4 | leucettamine b | 2.20 | 8 |
| 5 | Masoprocol | 0.69 | 1 |
About LTB4R as a Drug Target
LTB4R (leukotriene B4 receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented LTB4R interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
LTB4R inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.